Cardiovascular Disease Surveillance in the Comparative Effectiveness Landscape-Reference-Cited by-同舟云学术

Cardiovascular Disease Surveillance in the Comparative Effectiveness Landscape

Published:2009-09 Issue:5 Volume:2 Page:404-406
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ: Cardiovascular Quality and Outcomes

Author:

Roger Véronique L.¹

Affiliation:

1. From the Department of Health Sciences Research and Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.109.901249

Reference17 articles.

1. European Perspectives

2. Bishop E. Heart disease may actually be rising; researchers claim deaths are now being delayed to a later age group. Wall Street Journal. November 13 1996 1996;pB3(W) pB6(E) col 1 (11 col in).

3. Age- and Sex-Specific Trends in Fatal Incidence and Hospitalized Incidence of Stroke in Scotland, 1986 to 2005

4. Temporal Changes in the Use of Drug-Eluting Stents for Patients With Non–ST-Segment–Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention From 2006 to 2008

5. Sustaining Improvement in Door-to-Balloon Time Over 4 Years

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of cardiovascular disease in Europe;Nature Reviews Cardiology;2021-09-08

2. Seasonal and Geographic Patterns in Seeking Cardiovascular Health Information: An Analysis of the Online Search Trends;Mayo Clinic Proceedings;2018-09

3. Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?;Circulation: Cardiovascular Quality and Outcomes;2015-09

4. Prognostic Value of Cardiac Troponin T After Myocardial Infarction: A Contemporary Community Experience;Mayo Clinic Proceedings;2012-03

5. Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients;Expert Opinion on Drug Safety;2011-01-23